Concurrent Injection of Unlabeled Antibodies Allows Positron Emission Tomography Imaging of Programmed Cell Death Ligand 1 Expression in an Orthotopic Pancreatic Tumor Model

[Image: see text] Purpose: Among the treatment options for pancreatic ductal adenocarcinoma (PDAC) are antibodies against the programmed cell death receptor 1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway. Positron emission tomography (PET) has been successfully used to assess PD-1/PD-L1 sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun, Wen, Xiaoxia, Li, Tingting, Shi, Sixiang, Xiong, Chiyi, Wang, Yaoqi Alan, Li, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178348/
https://www.ncbi.nlm.nih.gov/pubmed/32337408
http://dx.doi.org/10.1021/acsomega.9b03731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178348/
https://www.ncbi.nlm.nih.gov/pubmed/32337408
http://dx.doi.org/10.1021/acsomega.9b03731

Ejemplares similares